Short- and long-term outcomes after percutaneous transluminal coronary angioplasty in chronic hemodialysis patients

✍ Scribed by Chi-Ling Hang; Mien-Cheng Chen; Bao-Jueng Wu; Chiung-Jen Wu; Sarah Chua; Morgan Fu

• Publisher: John Wiley and Sons
• Year: 1999
• Tongue: English
• Weight: 29 KB
• Volume: 47
• Category: Article
• ISSN: 1522-1946
• DOI: 10.1002/(sici)1522-726x(199908)47:4<430::aid-ccd10>3.0.co;2-1

✦ Synopsis

The aim of this study was to obtain data on the outcomes of chronic hemodialysis patients who underwent percutaneous transluminal coronary angioplasty (PTCA). A retrospective chart analysis identified 31 such patients between August 1992 and October 1996. The mean follow-up period was 12.4 ؎ 11.7 months. Angiographic success was achieved in 39 of 41 (95.1%) stenoses attempted. There were three in-hospital deaths. Clinical success was achieved in 28 of 31 patients (90%). Two of the 28 survivors were lost to follow-up. Recurrent angina developed within 6 months in 14 of 26 patients (53.8%). Eleven and 17 of the 26 patients (42.3% and 65.4%) died within 6 and 14 months, respectively, after the PTCA procedure. Ten of the 17 deaths (58.8%) were due to cardiovascular events. Our study suggests that PTCA is technically feasible with high angiographic success rate in chronic hemodialysis patients. In-hospital mortality rate and rate of recurrent angina are high. Long-term prognosis is poor.